PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $746,681 | -39.2% | 44,765 | +0.6% | 0.00% | – |
| Q2 2023 | $1,229,089 | +179.3% | 44,500 | +132.5% | 0.00% | – |
| Q1 2023 | $440,128 | +180.0% | 19,136 | +32.8% | 0.00% | – |
| Q4 2022 | $157,191 | +40.3% | 14,408 | +8.4% | 0.00% | – |
| Q3 2022 | $112,000 | -21.7% | 13,290 | -26.7% | 0.00% | – |
| Q2 2022 | $143,000 | -72.0% | 18,126 | -16.1% | 0.00% | – |
| Q1 2022 | $511,000 | -29.7% | 21,594 | +1.6% | 0.00% | – |
| Q4 2021 | $727,000 | +99.2% | 21,264 | +3.1% | 0.00% | – |
| Q3 2021 | $365,000 | -35.2% | 20,632 | +64.3% | 0.00% | – |
| Q2 2021 | $563,000 | +106.2% | 12,561 | +19.1% | 0.00% | – |
| Q1 2021 | $273,000 | +31.2% | 10,545 | +2.3% | 0.00% | – |
| Q4 2020 | $208,000 | +193.0% | 10,312 | +185.2% | 0.00% | – |
| Q3 2020 | $71,000 | +7.6% | 3,616 | -2.8% | 0.00% | – |
| Q2 2020 | $66,000 | +247.4% | 3,722 | +38.4% | 0.00% | – |
| Q1 2020 | $19,000 | -24.0% | 2,689 | -23.4% | 0.00% | – |
| Q4 2019 | $25,000 | -32.4% | 3,511 | +13.8% | 0.00% | – |
| Q3 2019 | $37,000 | +19.4% | 3,085 | +21.9% | 0.00% | – |
| Q2 2019 | $31,000 | +63.2% | 2,530 | +14.7% | 0.00% | – |
| Q1 2018 | $19,000 | -58.7% | 2,205 | 0.0% | 0.00% | – |
| Q4 2017 | $46,000 | +53.3% | 2,205 | +28.3% | 0.00% | – |
| Q3 2017 | $30,000 | +150.0% | 1,718 | +67.3% | 0.00% | – |
| Q2 2017 | $12,000 | -7.7% | 1,027 | 0.0% | 0.00% | – |
| Q1 2017 | $13,000 | -56.7% | 1,027 | -23.5% | 0.00% | – |
| Q4 2016 | $30,000 | – | 1,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |